BMP Pharma Trading AG (BST:BMP)

BMP Pharma Trading AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0	0	0	0	0
Revenue Growth (YoY)	2764.29%	-96.58%	-63.16%	345.20%	-
Cost of Revenue	0	0	0	0	0
Gross Profit	0	0	-0	0	-
Selling, General & Admin	1.7	1.64	1.12	0.68	0.59
Other Operating Expenses	0.21	0.21	0.06	0.12	0.1
Operating Expenses	1.91	1.85	1.18	0.8	0.7
Operating Income	-1.91	-1.85	-1.18	-0.8	-0.7
Interest Expense	-0	-0.01	-0.01	-0.01	-0
Interest & Investment Income	0.02	0.02	0.01	0	0.01
Currency Exchange Gain (Loss)	0	0	-	-0	0
Other Non Operating Income (Expenses)	6.09	5.93	3.4	4.02	0.99
Pretax Income	4.19	4.09	2.22	3.21	0.3
Income Tax Expense	1.31	1.34	0.65	0.59	0.13
Net Income	2.88	2.75	1.57	2.62	0.17
Net Income to Common	2.88	2.75	1.57	2.62	0.17
Net Income Growth	4.59%	75.39%	-40.06%	1440.37%	-44.98%
Shares Outstanding (Basic)	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5
EPS (Basic)	0.55	0.52	0.30	0.50	0.03
EPS (Diluted)	0.55	0.52	0.30	0.50	0.03
EPS Growth	4.59%	75.39%	-40.06%	1440.42%	-44.98%
Dividend Per Share	0.480	0.500	-	-	-
Dividend Growth	-4.00%	-	-	-	-
Gross Margin	14.28%	39.29%	-46.28%	12.29%	-
Operating Margin	-118988.15%	-3301448.21%	-72055.67%	-17878.21%	-69600.00%
Profit Margin	179523.63%	4916214.29%	95712.07%	58819.29%	17000.00%
EBITDA	-	-1.85	-	-0.8	-
D&A For EBITDA	-	0	-	0	-
EBIT	-1.91	-1.85	-1.18	-0.8	-0.7
Effective Tax Rate	31.31%	32.70%	29.30%	18.45%	42.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.